Login to Your Account



Cytox Raises $5.5M to Continue Alzheimer's Test Development

By Nuala Moran
Staff Writer

Wednesday, January 30, 2013
Cytox Ltd. has been rescued from liquidation and raised £3.5 million (US$5.5 million) in new money to reinvigorate efforts to develop a simple, definitive blood test for the early diagnosis of Alzheimer's disease.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription